China Medical Group (01093.HK): SYH2066 tablets approved for clinical trials in China.

Wisdom Financial News APP News, SinoPharm Group (01093.HK) announced that the SYH2066 tablet developed by the group has been approved by the National Medical Products Administration of the People's Republic of China in September 2025 and can conduct clinical trials in China.